Reply: Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders?

REPLY: We are grateful to Finessi et al. for their letter, which raises a crucial topic. We agree that many possible confounding factors may challenge the interplay between anthracycline-induced cardiotoxicity and myocardial 18F-FDG accumulation. Among them, steroids might profoundly interfere with